Teladoc CEO Jason Gorevic to leave the company

In a decision that surprised Wall Street analysts, Teladoc Health announced that long-time CEO Jason Gorevic will depart the company immediately.

In a statement, the board of directors said, CFO Mala Murthy will take over as the acting chief executive.

The leadership change comes as the virtual care company hunts for a path forward after a period of explosive growth during the Covid-19 pandemic. In February the company projected it would see single-digital growth for the next several years. Teladoc shares are down from its 2021 high of around $294, with the stock currently trading at around $14 a share.

Get unlimited access to award-winning journalism and exclusive events.

Neighborhood disadvantage found to affect blood pressure and cognition

New research from Wake Forest University School of Medicine suggests that living in a disadvantaged neighborhood is associated with higher blood pressure and lower cognitive

December 6, 2024

Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation | Psychedelic Invest

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”) today announced an effective date for its previously-announced share consolidation. At

November 20, 2024

Study identifies potential target for reversing drug resistance in ovarian cancer

For the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin.

September 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.